The Zhitong Finance App learned that Windward Bio Group, a clinical-stage biotech company headquartered in Switzerland, submitted an initial public offering (IPO) application to the US Securities and Exchange Commission (SEC) last Friday to raise up to 100 million US dollars.

Zhitongcaijing · 2d ago
The Zhitong Finance App learned that Windward Bio Group, a clinical-stage biotech company headquartered in Switzerland, submitted an initial public offering (IPO) application to the US Securities and Exchange Commission (SEC) last Friday to raise up to 100 million US dollars.